Clinical Trial Update: A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma [Phase 1, Phase 2]

View source ↗

Summary

The document reports results from a Phase 1/2 study evaluating intetumumab alone and in combination with dacarbazine in participants with stage 4 melanoma. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Dacarbazine (dacarbazine)
• Intetumumab (intetumumab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Melanoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2013-08-19